Score Your Stock

US stock · figures in US dollars · scored on full-year results

Mettler Toledo Mettler-Toledo International, Inc. Common Stock

MTD · Healthcare · Diagnostics & Research
Bottom 44% of scored stocks
OkayBottom 44% of scored stocks
Weak Spot

Mettler Toledo scores 51/100 on fundamentals: in the bottom 44% of 503 scored S&P 500 stocks. Its strongest area is Risk (83/100); its weakest is Price Fairness (0/100). It carries 1 warning flag: Weak Spot.

Best
Risk 83
Weakest
Price 0
  • Carries a Weak Spot flag

An expensively priced stock, but price fairness needs attention.

What looks good
What to watch
Mkt capUS$ 33.6b#306 of 503 in the S&P 500EPSUS$ 44.37P/E37.1×✗ vs sector median 29.6×P/B2,617×✗ vs sector median 3.7×Div yieldNo dividends paidBottom 6% in the S&P 50052w range · 92% of range1023.051728.66
as of 31 Oct 2026

Nearby peers

Ranks #34 of 60 in Healthcare by score

#1Universal Health Services79#32Biogen53#33Cencora53
#34Mettler Toledo51
#35Solventum51#36Thermo Fisher Scientific51

One-Minute Summary

Why Mettler Toledo scores 51

An expensively priced stock, but price fairness needs attention.

What looks good
What to watch

Business Strength

80
Why 80?
Pillar score: (2 + 1 + 1 + 2 + 2) = 8 of 10 points → 80
Return on Equity (ROE)7,062%Strong4-Year Revenue Growth+3%/yrOkay4-Year Profit Growth+5%/yrOkayNet Profit Margin22%StrongQuarterly Momentum+7%Strong
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↑ +14.8%Equity ↑ +108.5%ROE % 7,075%
Net ProfitEquityROE %
789m863m869m906m-150m-127m-24m13m202320242025TTM7,075%

Revenue & Net Profit, with Net Margin

Revenue ↑ +9.1%Net Profit ↑ +14.8%Net Margin % 21.9%
RevenueNet ProfitNet Margin %
3.8b3.9b4.0b4.1b789m863m869m906m202320242025TTM20.8%22.3%21.6%21.9%

Sales grew about 9.1% over 4 years: customers keep spending more with this company.

Profit climbed about 14.8% over 4 years: the business keeps more money as it grows.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +7.6%Net Profit ↑ +10.1%Net Margin % 22.7%
RevenueNet ProfitNet Margin %
955m1.0b884m983m1.0b1.1b947m1.0b212m252m164m202m218m286m170m233mQ3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'2622.2%24.1%18.5%20.6%21.1%25.3%17.9%22.7%
▬▲▼▼▬▲▬▲

Sales have stayed roughly flat over the last 8 quarters.

Profit grew about 10.1% over the last 8 quarters: the business is keeping more of what it earns.

Why 50?
Pillar score: (0 + 1 + 2) = 3 of 6 points → 50
Debt-to-Equity164.7×WeakCurrent Ratio1.1×OkayInterest Coverage16.8×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt → +1.5%Equity ↑ +108.5%D/E 165×
Total DebtEquityD/E
2.1b2.0b2.2b2.1b-150m-127m-24m13m202320242025TTM165×

Borrowings have stayed roughly level: manageable, as long as profits stay healthy.

Short-term assets vs bills, with Current Ratio

Current Assets ↑ +9.5%Current Liabilities → +1.6%Current Ratio 1.1×
Current AssetsCurrent LiabilitiesCurrent Ratio
1.2b1.2b1.4b1.3b1.2b1.2b1.2b1.2b202320242025TTM1×1×1.1×1.1×
Why 38?
Pillar score: (0 + 1 + 2 + 0) = 3 of 8 points → 38
Dividend QualityNo dividends paidWeak
Payout ratio: 0%
Operating Cash FlowPositive but bumpyOkayFree Cash FlowPositive & growingStrongCash & Cash EquivalentsShrinking & thinWeak
Show 3 charts

Operating vs Free Cash Flow

Operating CF → +1%Free CF → +0.4%
Operating CFFree CF
966m968m956m975m861m864m849m864m202320242025TTM

Cash keeps coming in, though unevenly: fine, but worth keeping an eye on.

Cash vs Total Debt

Cash ↓ -26.4%Short-Term Debt ↓ -65%Total Debt → +1.5%
CashShort-Term DebtTotal Debt
70m59m67m51m192m183m64m67m2.1b2.0b2.2b2.1b202320242025TTM

Dividends per Share, with Yield

DPS (cents) → +0%Yield % 0%
DPS (cents)Yield %
000020222023202420250%0%0%0%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 0?
Pillar score: (0 + 0 + 0) = 0 of 6 points → 0
P/E Ratio37.1×WeakP/B Ratio2,617×WeakPEG Ratio7.9Weak
Show chart

Share Price: Weekly Closes (not part of the score)

US$ 1674.81US$ 1353.22US$ 1031.64Oct '25Feb '26Jun '26Oct '26

The share price is up about 18.3% over the past year.

Why 83?
Pillar score: (2 + 1 + 2 + 2 + 1 + 2) = 10 of 12 points → 83
Earnings ConsistencySteadyStrongDebt Trend (4yr)StableOkayShare Count Trend (4yr)-2%/yrStrongInventory vs Sales (4yr)-0.8 pp/yr vs salesStrongAsset Turnover Trend (4yr)-0.2%OkayQuarterly Consistency0 of 4 quarters downStrong
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +9.1%Inventory ↑ +6.7%Inv. % of Rev. 10%
RevenueInventoryInv. % of Rev.
3.8b3.9b4.0b4.1b386m342m387m412m202320242025TTM10.2%8.8%9.6%10%
Ranks #34 of 60 in Healthcare by score

Sector peers

#1Universal Health Services79#32Biogen53#33Cencora53
#34Mettler Toledo (you)51
#35Solventum51#36Thermo Fisher Scientific51

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDiv yieldP/E RatioP/B RatioPEG Ratio
2026US$ 4.1bUS$ 905.6mUS$ 975.2mUS$ 864.0mUS$ -111.2mUS$ 51.4mUS$ 2.1bUS$ 67.3mUS$ 12.8mUS$ 1.3bUS$ 1.2bUS$ 3.7bUS$ 3.7bUS$ 411.6m-7062%22%164.7×1.1×16.8×----
2025US$ 4.0bUS$ 869.2mUS$ 955.8mUS$ 848.6mUS$ -107.1mUS$ 66.9mUS$ 2.2bUS$ 63.9mUS$ -23.6mUS$ 1.4bUS$ 1.2bUS$ 3.7bUS$ 3.7bUS$ 387.2mUS$ 0.0m-3677%22%-91.0×1.1×16.3×0%33.1×-1215.7×-
2024US$ 3.9bUS$ 863.1mUS$ 968.3mUS$ 864.4mUS$ -103.9mUS$ 59.4mUS$ 2.0bUS$ 182.6mUS$ -126.9mUS$ 1.2bUS$ 1.2bUS$ 3.2bUS$ 3.4bUS$ 342.3mUS$ 0.0m-680%22%-15.9×1.0×14.9×0%30.1×-204.4×7.7
2023US$ 3.8bUS$ 788.8mUS$ 965.9mUS$ 860.6mUS$ -105.3mUS$ 69.8mUS$ 2.1bUS$ 192.2mUS$ -149.9mUS$ 1.2bUS$ 1.2bUS$ 3.4bUS$ 3.5bUS$ 385.9mUS$ 0.0m-526%21%-13.9×1.0×13.6×0%33.1×-174.1×3.5